Biospace

Published September 14, 2026 · Updated September 15, 2026

Nasus Pharma Announces FDA Clearance to Initiate Clinical Study of NS002 in the ... - BioSpace

Read the full story at Biospace

This press release contains forward-looking statements within the ... Psychedelic therapies ride wave of public favor into FDA hearing.